AsclepiX appoints Dr. Amir Shojaei as Chief Scientific Officer and Executive Vice President, Clinical Development
Shojaei brings over two and a half decades of experience in clinical pharmaceutical developmentBALTIMORE, Oct. 08, 2021 (GLOBE NEWSWIRE) --...